Scarica l'app Stockscreener
22.25
2.05%
-0.465
Dopo l'orario di chiusura:
21.97
-0.285
-1.28%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNDM Giù?
Forum
Previsione
Frazionamento azionario
Tandem Diabetes Care Inc Borsa (TNDM) Ultime notizie
Renaissance Technologies LLC Purchases New Position in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Tandem Diabetes Care (NASDAQ:TNDM) Shares Cross Above 200-Day Moving AverageTime to Sell? - marketbeat.com
5 Must-Read Analyst Questions From Tandem Diabetes’s Q2 Earnings Call - Yahoo Finance
TNDM|Tandem Diabetes Care Inc|Price:22.617|Chg%:-0.513 - TradingKey
Tandem Diabetes (TNDM) Q2 2026 Earnings Call Transcript - AOL.com
(TNDM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Tandem Diabetes Care Inc (TNDM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
TNDM Q2 Loss Narrower Than Expected, Revenues Miss, Stock Up - The Globe and Mail
Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Analyzing 25% Potential Upside with No Sell Ratings - DirectorsTalk Interviews
Tandem Diabetes Care Inc (TNDM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Why Tandem Diabetes (TNDM) Stock Is Trading Up Today - Yahoo Finance
TNDM Q2 Deep Dive: Pharmacy Channel Gains and Pipeline Execution Amid Margin Recovery - Yahoo Finance
Tandem Diabetes Care, Inc. (TNDM) Stock forecasts - Yahoo Finance UK
Why Tandem Diabetes Care (TNDM) Is Up 14.8% After Record Q2 Sales And PayGo Momentum - finance.yahoo.com
Tandem Diabetes Care (TNDM) Could Be 23% Below Fair Value After Q2 Results - Yahoo Finance
Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? - stocktwits.com
Tandem Diabetes Care (TNDM) Stock Jumps As Margin Recovery Steals The Spotlight - Sahm
TNDM Maintained by Citigroup -- Price Target Raised to $21.00 - GuruFocus
Tandem Diabetes Care (NASDAQ:TNDM) Announces Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Deutsche Bank Adjusts Tandem Diabetes Care PT to $18 From $15.50, Maintains Hold Rating - Moomoo
Oppenheimer reiterates Tandem Diabetes stock rating on pharmacy gains By Investing.com - Investing.com South Africa
TNDM Maintained by RBC Capital -- Price Target Lowered to $26 - GuruFocus
Tandem Diabetes Care Is Maintained at Outperform by RBC Capital - Moomoo
Tandem Diabetes Care, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:TNDM) 2026-08-07 - Seeking Alpha
Tandem Diabetes Care's Underlying Q2 Trends Better Than Headline Suggests, RBC Says - marketscreener.com
Tandem Diabetes Care Q2 Earnings Call Highlights - MarketBeat
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap DownWhat's Next? - MarketBeat
Tandem Diabetes Care Inc (TNDM) Stock News Today - TradingKey
Tandem Diabetes Care, Inc. Stock 12‑Month Price Target Raised to $29.5, Implies 57% Upside - TradingView
RBC Adjusts PT on Tandem Diabetes Care to $26 From $30, Maintains Outperform Rating - marketscreener.com
Tandem Diabetes Care, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Tandem Diabetes Care Announces Second Quarter 2026 Financial Results - BioSpace
Tandem Diabetes Care earnings beat by $0.02, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Tandem Diabetes Care posts Q2 2026 profit beat - Investing.com Nigeria
TNDM Looks 37.4% Undervalued on GF Value™ Despite Unprofitable S - GuruFocus
TNDM Looks 37.4% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
Tandem Earnings: Few Surprises as the Firm Makes Progress With Mobi Pump - Morningstar
Is Tandem Diabetes Care Inc (TNDM) a Value Opportunity After Q2 Earnings Miss? GF Score: 66/100 - GuruFocus
Tandem Diabetes Care, Inc. (TNDM) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Tandem Diabetes Q2 2026 slides: PayGo model drives margin expansion - Investing.com
Tandem Diabetes Q2 2026 slides: margins surge amid PayGo shift - Investing.com
Tandem Diabetes’s (NASDAQ:TNDM) Q2 CY2026 Earnings Results: Revenue In Line With Expectations - Barchart.com
Tandem Diabetes Care, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Transcript : Tandem Diabetes Care, Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com
Earnings Flash (TNDM) Tandem Diabetes Care, Inc. Reports Q2 Revenue $254.6M, vs. FactSet Est of $255.0M - marketscreener.com
TANDEM DIABETES CARE INC 2026: Revenue $254.56M, EPS ($0.31) — 10-Q Summary - TradingView
Q2 2026 Tandem Diabetes Care Inc Earnings Call Transcript - GuruFocus
Tandem Diabetes Care Q2 revenue slightly misses estimates - TradingView
Tandem Diabetes Care reports Q2 2026 revenue $254.6M, gross margin 57% - TradingView
Tandem Diabetes Care (NASDAQ: TNDM) lifts Q2 sales to $254.6M, trims loss - Stock Titan
BRIEF-Tandem Diabetes Care Q2 Net Income USD -21.2 Million - TradingView
Tandem Diabetes Care, Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Voya Financial (TNDM holder) discloses 149,088 Tandem Diabetes Care shares in 13G/A - Stock Titan
Tandem Diabetes earnings on deck as pharmacy shift tests execution - Investing.com
Tandem Diabetes Earnings: What To Look For From TNDM - Barchart.com
Arrowstreet Capital Limited Partnership Raises Stake in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Exploring a Promising 41.84% Upside Potential - DirectorsTalk Interviews
Tandem Poised to Launch Tubeless Mobi Pump - Morningstar
Tandem Diabetes Care Target of Unusually High Options Trading (NASDAQ:TNDM) - MarketBeat
2.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):